FTRE
Fortrea Holdings Inc.
$15.43
-0.90%
2026-05-08
About Fortrea Holdings Inc.
Fortrea Holdings Inc., a contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide. It offers clinical pharmacology, such as clinical research units, external partnerships, project management, study design and monitoring, bioanalytics and biomarkers, pharmacokinetics, modeling and simulation, and biometrics; and clinical development, including phase I through IV clinical and real-world evidence studies, regulatory affairs, protocol design, operational planning, study and site start-up, patient recruitment, project management, comprehensive site and medical monitoring, data management and biostatistics, pharmacovigilance, medical writing, and mobile clinical services. The company also provides consulting services comprising product development and regulatory, market access and health economics, and outcomes research, as well as RWE services. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.
Key Fundamentals
Forward P/E
14.17
EPS (TTM)
$-4.81
ROE
-64.5%
Revenue Growth (YoY)
-2.3%
Profit Margin
-16.5%
Debt/Equity
212.70
Price/Book
2.48
Beta
1.91
Market Cap
$1.42B
Avg Volume (10D)
2.1M
Recent Breakout Signals
Recent Price Range (60 Days)
60D High
$16.19
60D Low
$8.55
Avg Volume
1.6M
Latest Close
$15.43
Get breakout alerts for FTRE
Sign up for Breakout Scanner to receive daily notifications when FTRE triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial. No card required.
Fortrea Holdings Inc. (FTRE) is listed on the NASDAQ (NASDAQ). Breakout Scanner monitors FTRE daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. FTRE operates in the Healthcare sector within the Biotechnology industry. Data is provided for informational purposes only and does not constitute financial advice.